November 5, 2019
Cancer Biomarkers: Improving Detection and Treatment
Explore the three main types of cancer biomarkers and their main uses in cancer diagnosis, informing prognosis, and guiding treatment decisions. Review the vast array of biomolecules which act as cancer biomarkers, including genetic, transcriptomic, epigenetic, proteomic, and metabolomic biomarkers.
LEARN MORE
October 30, 2019
The Biological Equivalence of PDXs and PDXOs
Learn about patient-derived xenograft (PDX) and PDX-derived organoid (PDXO) biological equivalence, based on shared ...
LEARN MORE
October 29, 2019
Advances in In Vivo Oncology Models at AACR-NCI-EORTC 2019
In Boston this week we’re presenting all the latest updates across our panels of in vivo oncology models. Catch up with ...
LEARN MORE
October 28, 2019
New Organoid Platforms for Oncology and I/O Drug Discovery at AACR-NCI-EORTC 2019
2019 has been an exciting year at CrownBio with the addition of organoid platforms to our portfolio of models and ...
LEARN MORE
October 28, 2019
Biomarker Discovery and MOA Evaluation through Genomic and Proteomic Profiling at AACR-NCI-EORTC 2019
This week in Boston we’re presenting data on our new analysis platform and preclinical technologies. This post recaps ...
LEARN MORE
October 25, 2019
How to Detect, Characterize, and Evaluate CAR-Ts: Top 13 Questions
Review key questions on preclinical models and rare cell analysis technology for assessing CAR-T cell therapies from ...
LEARN MORE
October 24, 2019
Graft-versus-Host Disease: Types and How to Model Them
Review the different types of graft-versus-host disease (GvHD) and the preclinical models (including humanized mice) used to study the condition.
LEARN MORE
October 22, 2019
Dietary Mouse Models of NASH: Comparing the AMLN Diets and the MS-NASH Mouse
Compare the key features of commercial dietary mouse models of NASH, including disease induction by the AMLN and GAN ...
LEARN MORE
October 4, 2019
What are PDX-Derived Organoids (PDXOs)?
Learn about PDX-derived organoids, including PDXO establishment and utility in a pioneering drug discovery platform ...
LEARN MORE
September 27, 2019
Preclinical Obesity Study Design: Top 10 Questions
Review the top 10 questions on optimizing preclinical obesity studies and model selection from our recent webinar, ...
LEARN MORE
September 19, 2019
Key Discoveries in the Development of Modern HUB Organoids
Learn about the key research discoveries leading to the development of modern HUB Organoids.
LEARN MORE
September 17, 2019
Targeting Tumor-Associated Antigens and Tumor-Specific Antigens
Learn more about targeting human tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs) in immunotherapy ...
LEARN MORE
September 13, 2019
HUB Tumor Organoids: Top 15 Questions
Review the key questions on HUB tumor organoids from our recent webinar, answered by Dr Sylvia Boj, Hubrecht Organoid ...
LEARN MORE
September 11, 2019
HUB Organoids: Top 9 Technical Questions
Review the top 9 technical questions on HUB organoid development from our recent webinar, answered by Dr Sylvia Boj, ...
LEARN MORE
September 10, 2019
How to Assess Immunotherapy Toxicity with NHP Models
How to Assess Immunotherapy Toxicity with NHP Models Explore non-GLP exploratory toxicology NHP studies as a rapid and ...
LEARN MORE
